Attached files
file | filename |
---|---|
10-K/A - Eloxx Pharmaceuticals, Inc. | v199713_10ka.htm |
EX-31.1 - Eloxx Pharmaceuticals, Inc. | v199713_ex31-1.htm |
EX-31.2 - Eloxx Pharmaceuticals, Inc. | v199713_ex31-2.htm |
EX-32.2 - Eloxx Pharmaceuticals, Inc. | v199713_ex32-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on
Form 10-K/A of Senesco Technologies, Inc. for the year ended June 30, 2010 as
filed with the Securities and Exchange Commission on the date hereof, the
undersigned, Leslie J. Browne, President and Chief Executive Officer, hereby
certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The
Annual Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
(2) The
information contained in the Annual Report fairly presents, in all material
respects, the financial condition and results of operations of Senesco
Technologies, Inc.
Dated: October
25, 2010
|
/s/ Leslie J. Browne *
|
|
Leslie
J. Browne
|
||
President
and Chief Executive Officer
|
||
(principal
executive officer)
|
* A
signed original of this written statement required by Section 906 has been
provided to us and will be retained by us and furnished to the Securities and
Exchange Commission or its staff upon request.